Skip to main content
DAIKEN MEDICAL CO.,LTD logo

DAIKEN MEDICAL CO.,LTD — Investor Relations & Filings

Ticker · 7775 ISIN · JP3482500000 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2023-11-01 Interim / Quarterly Rep…
Country JP Japan
Listing T 7775

About DAIKEN MEDICAL CO.,LTD

https://daiken-iki.co.jp/en/

DAIKEN MEDICAL CO., LTD. is a medical device manufacturer that develops, produces, and sells original products. The company specializes in equipment for anesthesia, infection control, and suction applications. Its main product lines include the COOPDECH brand of syringe pumps and patient-controlled analgesia (PCA) devices, alongside various suction systems and endotracheal tubes. The company's approach is based on integrating insights from clinical practice with its research, development, and manufacturing technologies to create advanced medical solutions for the global healthcare market.

Recent filings

Filing Released Lang Actions
四半期報告書－第56期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Daiken Medical Co., Ltd. for the second quarter of the 56th fiscal period (ending September 30, 2023). It contains detailed financial statements, including the balance sheet, profit and loss statement, and cash flow statement, as well as management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2024
2023-11-01 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references the Financial Instruments and Exchange Act (金融商品取引法). It serves as an officer certification confirming the accuracy of the company's quarterly report (第１四半期報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. Q1 2023
2023-08-01 Japanese
四半期報告書－第56期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Daiken Medical Co., Ltd. in Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and notes to the financial statements for the first quarter of the fiscal year ending March 31, 2024. It is a substantive financial report rather than an announcement or certification, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-01 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This is a mandatory document that accompanies the Annual Securities Report (Yukashoken Hokokusho) in Japan, confirming the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'Audit Report' or 'Management Report', it is best classified as a Regulatory Filing (RNS). FY 2023
2023-06-21 Japanese
内部統制報告書－第55期(2022/04/01－2023/03/31)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of regulatory filing, which focuses on governance and internal control compliance rather than financial results or management changes, falls under the 'Regulatory Filings' category as it is a specific statutory requirement in Japan that does not fit into the other specialized categories like 10-K or CGR.
2023-06-21 Japanese
有価証券報告書－第55期(2022/04/01－2023/03/31)
Annual Report Classification · 1% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which translates to 'Annual Securities Report'. This is the standard, comprehensive annual financial filing required by the Financial Services Agency of Japan under the Financial Instruments and Exchange Act. It contains detailed financial statements, business descriptions, and management analysis for the fiscal year ending March 31, 2023. It fits the definition of an Annual Report (10-K equivalent). FY 2023
2023-06-21 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.